GBS Inc. Announces its Pre-Submission package is with the FDA
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic...
Month: October 2021
Rezolute Announces Pricing of Public Offering of $55 million of Common Stock and Pre-Funded Warrants, and Concurrent Registered Direct Offering
REDWOOD CITY, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical...
Resverlogix to Present at Upcoming Conferences
Presentation Highlights will Include First-in-Class Epigenetic Small Molecule Candidate Apabetalone Being Evaluated as Potential Treatment for COVID-19CALGARY, Alberta, Oct. 13,...
New HBM+ report shares key insights on rapidly evolving drug landscape
TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- With the COVID-19 pandemic fundamentally changing health care delivery across the country, a...
Selecta Biosciences to Present New Data for the ImmTOR™ platform at the ESGCT 28th Annual Congress
WATERTOWN, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated...
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or...
Weston Family Foundation donates $3 million to the Canadian Mental Health Association to support the mental health of youth and underserved populations
TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- The Weston Family Foundation is donating $3 million to the Canadian Mental Health...
TRACON Pharmaceuticals Announces Appointment of Carol Lam to its Board of Directors
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development...
Amedisys Announces Third Quarter Earnings Release and Conference Call Date
BATON ROUGE, La., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice,...
Recent 24-Month Real-World PALADIN Data Demonstrate the Ability of ILUVIEN® to Significantly Reduce Treatment Burden in Patients with Diabetic Macular Edema
PALADIN Study Data Presented at the American Society of Retina Specialists Shows That Post-ILUVIEN, the Percentage of Eyes Receiving One...
BioVie Hosting Key Opinion Leader Webinar on Neuroinflammation and Insulin Resistance and New Treatment Approaches for Alzheimer’s Disease
SANTA MONICA, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
PepGen Welcomes Esteemed Neurologist Dr. John Day to Scientific Advisory Board
BOSTON, Oct. 13, 2021 (GLOBE NEWSWIRE) -- PepGen, Inc., a company advancing next-generation oligonucleotide therapies for neuromuscular and neurologic diseases, today...
ORYZON presents safety and efficacy data of vafidemstat from the Phase II SATEEN trial in multiple sclerosis at ECTRIMS-2021
Long-term vafidemstat treatment was safe and well tolerated with drug exposures up to 2 yearsAnti-inflammatory activity observed in vafidemstat-treated patientsSATEEN...
Vaccitech to Present an Update on Its Chronic HBV Infection Immunotherapeutic Program at The World Vaccine Congress Europe
OXFORD, United Kingdom, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the...
Mereo BioPharma, the Osteogenesis Imperfecta Federation Europe (OIFE) and the Osteogenesis Imperfecta Foundation (OIF) announces completion of the IMPACT Survey enrollment
Living With Osteogenesis IMPerfecta: UnderstAnding Experiences Based On Community InsighT and Evidence Survey, the IMPACT SurveyMore than 2200 individual responses...
Inovalon to Host Virtual Client Congress October 18-19, 2021
Former CMS Administrator Seema Verma, Snowflake CEO Frank Slootman, and Aetna/CVS Chief Medical Officer Dr. Kyu Rhee to Deliver Keynotes...
XORTX Therapeutics Announces Pricing of US$12 Million Public Offering and Nasdaq Listing
CALGARY, Alberta, Oct. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a...
Industry-veteran Elisa Cascade Joins Science 37 as Chief Product Officer; Chris Ceppi appointed Chief Technology Officer
Science 37 strengthens its senior executive leadership team, adding key talent to enhance the technology platform underpinning its Operating SystemLOS...
Dyne Therapeutics Highlights Preclinical Data and Clinical Development Plans for DMD and DM1 Programs at Inaugural R&D Day
- Investigational New Drug (IND) Submissions Anticipated for DYNE-251 in DMD During the Fourth Quarter of 2021 and for DYNE-101...
Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Ingestible Therapeutics Technologies
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the...
